17.80
Structure Therapeutics Inc Adr stock is traded at $17.80, with a volume of 943.72K.
It is down -0.17% in the last 24 hours and down -14.18% over the past month.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
See More
Previous Close:
$17.83
Open:
$18.19
24h Volume:
943.72K
Relative Volume:
1.21
Market Cap:
$1.02B
Revenue:
-
Net Income/Loss:
$-100.44M
P/E Ratio:
-8.018
EPS:
-2.22
Net Cash Flow:
$-105.32M
1W Performance:
-2.57%
1M Performance:
-14.18%
6M Performance:
-40.61%
1Y Performance:
-52.39%
Structure Therapeutics Inc Adr Stock (GPCR) Company Profile
Name
Structure Therapeutics Inc Adr
Sector
Industry
Phone
(628) 229-9277
Address
611 GATEWAY BLVD SUITE 223, SOUTH SAN FRANCISCO
Compare GPCR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
GPCR
Structure Therapeutics Inc Adr
|
17.80 | 1.03B | 0 | -100.44M | -105.32M | -2.22 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Structure Therapeutics Inc Adr Stock (GPCR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-02-25 | Initiated | Citigroup | Buy |
Feb-28-25 | Initiated | William Blair | Outperform |
Jan-08-25 | Initiated | Stifel | Buy |
Dec-04-24 | Initiated | H.C. Wainwright | Buy |
Sep-23-24 | Initiated | Morgan Stanley | Overweight |
May-21-24 | Initiated | JP Morgan | Overweight |
Apr-09-24 | Initiated | Cantor Fitzgerald | Overweight |
Oct-19-23 | Initiated | JMP Securities | Mkt Outperform |
Jul-27-23 | Initiated | Piper Sandler | Overweight |
May-25-23 | Resumed | Jefferies | Buy |
Feb-28-23 | Initiated | BMO Capital Markets | Outperform |
Feb-28-23 | Initiated | Guggenheim | Buy |
Feb-28-23 | Initiated | Jefferies | Buy |
Feb-28-23 | Initiated | SVB Securities | Outperform |
View All
Structure Therapeutics Inc Adr Stock (GPCR) Latest News
Chefs’ Warehouse (NASDAQ:CHEF) Reaches New 52-Week High After Better-Than-Expected Earnings - Defense World
Brokerages Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $65.50 - Defense World
Brookfield (NYSE:BN) Upgraded at National Bank Financial - Defense World
Camden National (NASDAQ:CAC) Stock Price Down 7.6% Following Weak Earnings - Defense World
Century Lithium (OTC:CYDVF) Shares Down 2.6% – What’s Next? - Defense World
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Shares Down 0.9% – Here’s What Happened - Defense World
HCM Acquisition (NASDAQ:HCMA) Stock Price Down 3.4% – Here’s Why - Defense World
DeFi Technologies (OTC:DEFTF) Trading 20% Higher – What’s Next? - Defense World
GCM Grosvenor (NASDAQ:GCMGW) Trading Up 1.1% – Should You Buy? - Defense World
Encore Capital Group (NASDAQ:ECPG) & Manhattan Bridge Capital (NASDAQ:LOAN) Critical Review - Defense World
Obesity Clinical Trials, Companies, Therapeutic Assessment, - openPR.com
Analysts Are Bullish on These Healthcare Stocks: Thermo Fisher (TMO), Viking Therapeutics (VKTX) - The Globe and Mail
Private Advisor Group LLC Buys 489 Shares of Quanta Services, Inc. (NYSE:PWR) - Defense World
Analysts Are Bullish on Top Healthcare Stocks: HOYA (HOCPF), Align Tech (ALGN) - The Globe and Mail
Microchip Technology Incorporated (NASDAQ:MCHP) Holdings Decreased by Private Advisor Group LLC - Defense World
Amazon.com, Inc. (NASDAQ:AMZN) Shares Sold by Shilanski & Associates Inc. - Defense World
Arcosa, Inc. (NYSE:ACA) Shares Sold by Cerity Partners LLC - Defense World
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and Sarepta Therapeutics (SRPT) - The Globe and Mail
Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target - Business Wire
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Eli Lilly & Co (LLY) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Alkermes (ALKS) - The Globe and Mail
H.C. Wainwright Sticks to Its Buy Rating for Structure Therapeutics, Inc. Sponsored ADR (GPCR) - The Globe and Mail
Principal Financial Group Inc. Has $14.24 Million Stock Holdings in Universal Display Corporation (NASDAQ:OLED) - Defense World
Principal Financial Group Inc. Decreases Stock Holdings in Shift4 Payments, Inc. (NYSE:FOUR) - Defense World
Principal Financial Group Inc. Sells 11,305 Shares of Nova Ltd. (NASDAQ:NVMI) - Defense World
Principal Financial Group Inc. Lowers Holdings in Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) - Defense World
Analysts Offer Insights on Healthcare Companies: Corbus Pharmaceuticals (CRBP), Amedisys (AMED) and Xoma (XOMA) - The Globe and Mail
Structure in partnering talks for GLP-1 pill as mid-stage readout nears - Endpoints News
Scage Future shares rise 2.16% in after-hours after extending business merger agreement deadline and establishing ADR facility. - AInvest
Structure Therapeutics Holds 2025 Annual Shareholders Meeting - TipRanks
Structure Therapeutics (NASDAQ:GPCR) Receives “Market Outperform” Rating from JMP Securities - Defense World
TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure - Business Wire
Breakthrough Oral Obesity Drug Matches Injectable Results, Shows Added Benefits With Wegovy in Trial Data - Stock Titan
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail
Data-Based Insights About Structure Therapeutics Inc ADR (GPCR) - Stocksregister
Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™METRO - METRO - NEWS CHANNEL NEBRASKA
Cantor Fitzgerald Comments on GPCR FY2026 Earnings - Defense World
Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarketsNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Cantor Fitzgerald Estimates GPCR FY2025 Earnings - Defense World
Oral Proteins and Peptides Market Report Latest Trends and Future Opportunities Analysis - openPR.com
Structure Therapeutics Inc. (NASDAQ:GPCR) Given Average Recommendation of “Buy” by Brokerages - Defense World
Structure Therapeutics, Inc.: Catalyst-Rich Outlook and Strategic Preparations Support Buy Rating - TipRanks
Bank of America Corp DE Has $1.47 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Viking Therapeutics at Jefferies Conference: Promising Weight Loss Drug - Investing.com
GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health - The National Law Review
Structure Therapeutics Set for Jefferies and Goldman Sachs Healthcare Conference Presentations in June - Stock Titan
Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints - standard-journal.com
BNP Paribas Financial Markets Increases Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
BNP Paribas Financial Markets Makes New $304,000 Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Bucking Biotech's Downward Trend, Circle Pharma Heads To Larger Space - Bisnow
Analysts Have Conflicting Sentiments on These Healthcare Companies: Novo Nordisk (NVO), Beam Therapeutics (BEAM) and TScan Therapeutics (TCRX) - The Globe and Mail
Structure Therapeutics Inc Adr Stock (GPCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):